Concepedia

Publication | Open Access

Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment

DOIFull Paper Access

35

Citations

51

References

2010

Year

Smitha Reddy, Calvin Shaller, Mohan Doss, Irina Shchaveleva, James D. Marks, Jian Q. Yu, Matthew K. Robinson
Clinical Cancer Research

Abstract

These studies suggest that (124)I-C6.5 db-based imaging can be used to evaluate HER2 levels as a predictor of response to HER2-directed therapies.

References

YearCitations

Page 1